H1N1 Influenza-A Virus New Caledonia/20/99 Recombinant, H1N1 New Caledonia, 10ug

CAT No.BT-IHA-001

H1N1 Influenza-A Virus New Caledonia/20/99 Recombinant, H1N1 New Caledonia, 10ug

---

Description
Recombinant Full-Length H1N1 New Caledonia/20/99 is glycosylated with N-linked sugars, produced using baculovirus vectors in insect cells and its Mw is approximately 72 kDa.
The insect cells infected with A9440.1a recombinant baculovirus expressing recombinant H1N1 A/New Caledonia/20/99.
H1N1 New Caledonia shows 90% similarity to the A/PR/8/34 amino acid sequence.
The accession number is DQ508857.

Formulation
The Recombinant H1N1 A/New Caledonia/20/99 solution 10mM Sodium phosphate, pH 7.2, 150mM NaCl.

Immunological Activity
Western-Blot 0.1ug -1ug per strip, ELISA 1ug/Well.

Sterile Filtered colorless solution.

Purity
Greater than 90.0% as determined by:
Analysis by SDS-PAGE, HA1 and HA2 bands are observed using SDS-PAGE under reducing conditions.

Source
Baculovirus Insect Cells.

Stability
H1N1 A/New Caledonia/20/99Recombinant should be stored at 4?C.

Usage
TSZGENE's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.